APA

Kröger N., Zabelina T., Berger J., Duske H., Klyuchnikov E., Binder T., Stübig T., Hilde-brandt Y., Atanackovic D., Alchalby H., Ayuk F., Zander A. R., Bacher U. & Eiermann T. (20111121). Donor KIR haplotype B improves progression-free and overall survival after allogeneic hematopoietic stem cell transplantation for multiple myeloma. : Leukemia.

Chicago

Kröger N, Zabelina T, Berger J, Duske H, Klyuchnikov E, Binder T, Stübig T, Hilde-brandt Y, Atanackovic D, Alchalby H, Ayuk F, Zander A R, Bacher U and Eiermann T. 20111121. Donor KIR haplotype B improves progression-free and overall survival after allogeneic hematopoietic stem cell transplantation for multiple myeloma. : Leukemia.

Harvard

Kröger N., Zabelina T., Berger J., Duske H., Klyuchnikov E., Binder T., Stübig T., Hilde-brandt Y., Atanackovic D., Alchalby H., Ayuk F., Zander A. R., Bacher U. and Eiermann T. (20111121). Donor KIR haplotype B improves progression-free and overall survival after allogeneic hematopoietic stem cell transplantation for multiple myeloma. : Leukemia.

MLA

Kröger N, Zabelina T, Berger J, Duske H, Klyuchnikov E, Binder T, Stübig T, Hilde-brandt Y, Atanackovic D, Alchalby H, Ayuk F, Zander A R, Bacher U and Eiermann T. Donor KIR haplotype B improves progression-free and overall survival after allogeneic hematopoietic stem cell transplantation for multiple myeloma. : Leukemia. 20111121.